WHO ICTRP trial

Evaluation of the Diagnostic Performance of TYRO3 Protein as a Novel Biomarker…

ChiCTR2500109664 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500109664
Public title Evaluation of the Diagnostic Performance of TYRO3 Protein as a Novel Biomarker for Diabetic Kidney Disease
Scientific title Evaluation of the Diagnostic Performance of TYRO3 Protein as a Novel Biomarker for Diabetic Kidney Disease
Primary sponsor The 7th Division Hospital of Xinjiang Production and Construction Corps
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Countries China
Conditions Diabetic kidney disease
Interventions DKD group:None;Type 2 diabetes group:None;Healthy control group:None
Registration date Sep 23, 2025
Target size DKD group:50;Type 2 diabetes group:50;Healthy control group:50
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations